Le Lézard
Classified in: Health
Subject: FDA

ZipThaw Receives FDA Clearance for Clinical Use


SAN DIEGO, Jan. 6, 2020 /PRNewswire/ -- FreMon Scientific is pleased to announce the FDA has now cleared ZipThawtm for frozen plasma thawing as a Class II medical device. ZipThaw, used with the ZipSleevetm anti-contaminant disposable barrier, is the world's first dry and portable precision plasma thawing system. Clinicians can now deliver vital plasma to patients at the right time and temperature.

ZipThaw

ZipThaw and ZipSleeve have earned CE Mark, ISO certification, UL Listing and now FDA clearance for thawing fresh frozen plasma (FFP) and plasma frozen within 24 hours after phlebotomy (FP24).

"We are delighted with the FDA's clearance of ZipThaw as an effective and safe plasma thawing device for clinical use," said FreMon Scientific CEO Dr. Farideh Bischoff.

"ZipThaw delivers plasma to patients requiring transfusions, and with ZipSleeve's patented sensors, the system gives accurate, degree-by-degree measurement of the specimen's actual temperature during the thawing process, not its surroundings. Today marks a new era in plasma thawing for patients, clinicians, and researchers seeking a more effective approach that is efficient, reproducible and safe."

In most of the world, blood banks thaw plasma using hot water baths. The water baths are heavy, they require significant bench space, they are difficult to keep clean and often lead to waste since clinicians have to pre-order thawed plasma from a central location. They also only measure ambient water temperature, not the specimen's actual temperature.

FreMon Scientific has designed the next generation thawing device that is safe, dry, easy to use, light enough to carry, and that uses a disposable, medical-grade sleeve to reduce contamination and increase accuracy. ZipThaw is proven to preserve coagulation factors needed in life saving transfusion procedures.

ZipThaw requires nearly no maintenance, thawing is precisely measured and the end-to-end thawing process is easier to manage with fewer technical staff.

"We are excited to start the new year with the opportunity to provide clinicians with an effective device that can improve their patients' lives," says CEO Dr. Bischoff.

Learn more about ZipThaw and ZipSleeve: fremonscientific.com.

About FreMon Scientific

FreMon Scientific, in San Diego, CA, is dedicated to the safe and efficient processing and use of lifesaving blood, plasma and tissue products. FreMon Scientific creates platforms and devices that are easy to use, fast, low cost and that enable inventory management. Improving patient safety and outcomes are our most critical business goals. FreMon Scientific is cleared to sell ZipThaw and ZipSleeves in all FDA and CE Mark territories. ZipThaw and ZipSleeve are manufactured in the USA.

Contact:
Dr. Farideh Bischoff
Chief Executive Officer
[email protected] 
832-722-9690

ZipThaw & ZipSleeve

SOURCE FreMon Scientific, Inc.


These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: